These data suggest that p38 phosphorylation induced by Brk expression in non-transformed mammary epithelium could contribute to breast disease as either an early event (allowing pro-survival and/or luminal filling) or late event (migration/dissemination, therapy resistance) in tumorigenesis, thereby leading to a poor prognosis. Here, MAPK14 is linked to breast disorder.